Last updated on September 2019

GN39763: A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY, AND SAFETY STUDY OF MTAU9937A IN PATIENTS WITH PRODROMAL TO MILD ALZHEIMER’S DISEASE


Brief description of study

Research Study for Prodromal to Mild Alzheimer's Disease.

 

Clinical Study Identifier: TX207240

Find a site near you

Start Over

Pharmacology Research Institute, Newport Beach

1601 Dove Street, Suite 290 Newport Beach, CA United States
  Connect »